Skip to content

Clinical trials

Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 3 Country / region: Austria Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20096
20111
20121
20132
20143
20162
20172
20192
20212
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting7
Recruiting3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
German CLL Study Group5
BeOne Medicines3
Loxo Oncology, Inc.3
AbbVie2
Acerta Pharma BV2
Celgene2
Pharmacyclics LLC.2
SecuraBio2
Arbeitsgemeinschaft medikamentoese Tumortherapie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell33
Lymphoma, Non-Hodgkin6
Leukemia4
Hematologic Diseases3
Lymphoma3
Lymphoma, B-Cell3
Neoplasms3
Bronchiolitis Obliterans Syndrome2
Leukemia, B-Cell2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.